New drug safety advice from the MHRA regarding
Valproate: NHSGGC Stakeholders Meeting
Posted: Friday, May 18, 2018
Category - Medicines Update
Medicines Update
For all healthcare professionals across NHSGGC both in primary care and the acute sector.
- Subscribe to our blog via email: medicines.update@ggc.scot.nhs.uk
- Follow us on Twitter
Please note, Medicines Update blogs are correct at the time of publication.
Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact medicines.update@ggc.scot.nhs.uk.
Click here for further information on Medicines Update.
If you would like to contribute to Medicines Update, click here for a guide to blog writing and the checklist to complete prior to submitting a blog to the Communications Subcommittee of ADTC.
Drug Safety Information: valproate medicines
Posted: Thursday, May 3, 2018
Category - Medicines Update
Important new drug safety information from the MHRA regarding
Edoxaban is the DOAC of choice in non-valvular atrial fibrillation
Posted: Thursday, May 3, 2018
Category - Medicines Update
The following is a joint quote from David Murdoch, Chair of the Heart MCN and Christine McAlpine, Chair of the Stroke MCN in NHSGGC. “The Heart MCN supported by the Stroke MCN have updated the atrial fibrillation (AF)&nb...